Program

Be the Voice in CF Research

Ella Balasa
Adult with CF
Ella Balasa
Wait – CFTR isn’t Just in the Lungs?!?

Drucy Borowitz
Senior Vice President of Community Partnerships, Cystic Fibrosis Foundation
Drucy Borowitz
Be the Voice in CF Research

JP Clancy, MD
Vice President of Clinical Research, Cystic Fibrosis Foundation
JP Clancy, MD
After Trikafta: The Future of Modulators and Potential Effects on Treating CF

Patrick Flume
Professor of Medicine and Pediatrics, University of South Carolina
Patrick Flume
The Three R’s of CFTR: Restore, Repair, Replace
CF 101: Decoding CFTR Genetics to Transform Treatment
Closing

James Lawlor
Adult with CF
James Lawlor
Sexual and Reproductive Health in the Era of CFTR Modulators

Megan Lepore
Adult with CF
Megan Lepore
Therapeutic Approaches for Rare and Nonsense Mutations

Xan Nowakowski
Assistant Professor in the Geriatrics and Behavioral Sciences and Social Medicine Departments at Florida State University College of Medicine and Adult with CF
Xan Nowakowski
Sexual and Reproductive Health in the Era of CFTR Modulators

Jennifer Taylor-Cousar
Associate Professor of Adult and Pediatric Pulmonary Medicine, National Jewish Health
Jennifer Taylor-Cousar
Changing CF Care in the Era of Trikafta: Are We There Yet?

Dave Nichols
Associate Professor of Pediatrics, Seattle Children’s Hospital at the University of Washington
Dave Nichols
After Trikafta: The Future of Modulators and Potential Effects on Treating CF

George Retsch-Bogart, MD
Professor of Pediatrics at the University of North Carolina at Chapel Hill
George Retsch-Bogart, MD
Therapeutic Approaches for Rare and Nonsense Mutations

Peter Haggie, PhD
Associate Professor, Medicine at the University of California, San Francisco
Peter Haggie, PhD
CF 101: Decoding CFTR Genetics to Transform Treatment

Elinor Langfelder-Schwind
Genetic Counselor, Regulatory Research Coordinator at Beth Israel Medical Center
Elinor Langfelder-Schwind